Literature DB >> 9222196

Sensory ataxic neuropathy as the presenting feature of a novel mitochondrial disease.

R Fadic1, J A Russell, V V Vedanarayanan, M Lehar, R W Kuncl, D R Johns.   

Abstract

Four unrelated patients presented with a severe sensory ataxic neuropathy in association with dysarthria and chronic progressive external ophthalmoplegia. Electrophysiologic and pathologic studies showed severe axonal loss disproportionately affecting sensory nerves. Molecular genetic analysis revealed multiple mitochondrial DNA deletions in muscle and peripheral nerve. Sensory ataxic neuropathy may be the predominant and presenting manifestation of a mitochondrial disorder, and a mitochondrial etiology should be included in its differential diagnosis. The triad of sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (SANDO) may represent a novel mitochondrial disease associated with multiple mitochondrial DNA deletions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9222196     DOI: 10.1212/wnl.49.1.239

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  22 in total

Review 1.  Clinical mitochondrial genetics.

Authors:  P F Chinnery; N Howell; R M Andrews; D M Turnbull
Journal:  J Med Genet       Date:  1999-06       Impact factor: 6.318

2.  Late-onset presentation of POLG1-associated mitochondrial disease.

Authors:  Bruna Meira; Rafael Roque; Miguel Pinto; André Caetano
Journal:  BMJ Case Rep       Date:  2019-03-31

3.  MELAS/SANDO overlap syndrome associated with POLG1 mutations.

Authors:  Niels Hansen; Thomas Zwarg; Isabel Wanke; Stephan Zierz; Oliver Kastrup; Marcus Deschauer
Journal:  Neurol Sci       Date:  2011-06-07       Impact factor: 3.307

Review 4.  Clinical and molecular features of POLG-related mitochondrial disease.

Authors:  Jeffrey D Stumpf; Russell P Saneto; William C Copeland
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-04-01       Impact factor: 10.005

Review 5.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

Review 6.  Progressive external ophthalmoplegia characterized by multiple deletions of mitochondrial DNA: unraveling the pathogenesis of human mitochondrial DNA instability and the initiation of a genetic classification.

Authors:  Gert Van Goethem; Jean-Jacques Martin; Christine Van Broeckhoven
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

7.  Mitochondrial DNA abnormalities in ophthalmological disease.

Authors:  Grainne S Gorman; Robert W Taylor
Journal:  Saudi J Ophthalmol       Date:  2011-02-18

Review 8.  Mitochondrial disease in childhood: nuclear encoded.

Authors:  Amy C Goldstein; Poonam Bhatia; Jodie M Vento
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

9.  Sensory neuronopathy in patients harbouring recessive polymerase γ mutations.

Authors:  Nichola Z Lax; Roger G Whittaker; Philippa D Hepplewhite; Amy K Reeve; Emma L Blakely; Evelyn Jaros; Paul G Ince; Robert W Taylor; Peter R W Fawcett; Doug M Turnbull
Journal:  Brain       Date:  2011-12-20       Impact factor: 13.501

10.  Rod bipolar cell dysfunction in POLG retinopathy.

Authors:  Kit Green Sanderson; Eoghan Millar; Anupreet Tumber; Regan Klatt; Neal Sondheimer; Ajoy Vincent
Journal:  Doc Ophthalmol       Date:  2020-06-21       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.